Podbit · The Peter Attia Drive
Melatonin doesn't knock you out — it tells your brain what time it is. The optimal dose to shorten sleep latency is just 4 mg, yet most people take 5–10 mg, which can backfire by disrupting circadian alignment. And commercial product accuracy is so poor that actual content can range from 80% below to nearly 500% above the label claim.
Where this was said
At 35:50 · chapter starts 27:15
During slow-wave sleep, the brain's glymphatic system activates — neurons shrink slightly, opening about 60% more interstitial space, allowing CSF to circulate freely and carry away metabolic toxins including beta-amyloid and aberrant tau proteins implicated in Alzheimer's disease. Animal studies show glymphatic amyloid clearance roughly doubles during sleep, especially deep slow-wave sleep. Human studies confirm that even a single night of sleep deprivation impairs this clearance, and chronic disruption correlates with long-term amyloid and tau burden. The accumulation of these proteins in turn damages the brain regions that regulate sleep, creating a vicious cycle. Researcher David Holtzman suspected an orexin-amyloid link, since both orexin levels and CSF amyloid follow similar diurnal rhythms. His group infused orexin into mouse hippocampi and found it raised interstitial amyloid; the early DORA almorexant lowered it. Dayvigo in tau-mutant mice slowed tau pathology and brain atrophy in male mice. In a landmark 2023 human trial of 38 adults aged 45–65, 20 mg of Belsomra — but not 10 mg — reduced CSF amyloid-beta by ~20%. Ambien had no such effect. This specificity is critical: simple unconsciousness isn't doing the clearing. Three new clinical trials — two with ~200 subjects each — are underway and expected to report between now and 2029.
DORAs work by dialing down the brain's orexin-driven wakefulness system rather than forcing sedation — a fundamentally different mechanism that preserves sleep architecture and even improves REM sleep. Meta-analyses show superior sleep efficiency and tolerability compared to older drug classes.
The brain's glymphatic waste-clearance system — which flushes amyloid and tau during deep sleep — roughly doubles its clearance rate during slow-wave sleep. DORAs preserve that architecture, and a 2023 human trial found 20 mg of suvorexant reduced CSF amyloid-beta by about 20%. The data are early but the signal is strong enough to warrant close attention.
During sleep, neurons shrink slightly, opening about 60% more interstitial space, allowing the glymphatic system to flush beta-amyloid and tau proteins from the brain.
Animal studies show glymphatic clearance of beta-amyloid roughly doubles during sleep, particularly during deep non-REM slow-wave sleep.
In a 2023 human trial, 20 mg of suvorexant (Belsomra) decreased CSF amyloid-beta by roughly 20% starting about 5 hours after administration.
AI nailed Andrew Huberman's vertigo-vs-low-blood-pressure diagnosis because that pattern has been reported millions of times. But every patient's liver is different and data on liver surgeries is scarce worldwide — making solo robot surgery dangerous. The rule is simple: data abundance means AI can help; data scarcity means keep the human in the loop.
Fei-Fei Li's father had liver surgery performed by a da Vinci robot guided by a surgeon. The result: 10 times less blood loss than a typical procedure. This isn't replacement — it's the gold standard of human-machine collaboration, where the human's judgment and the robot's precision combine.
US drug overdose deaths fell from 110,000 to roughly 70,000 — the biggest CDC-recorded single-year drop ever. Men's rates fell 27% in one year, and the steepest decline of all was among 15–24-year-olds, down 37%. The crisis narrative around young men needs to make room for signs of genuine progress.
Kessler thought his grief expertise would protect him. It didn't. When his son David died unexpectedly, he found himself on the floor — and eventually realized that acceptance alone wasn't enough. That unmet need became the sixth stage: finding meaning.
Grief isn't just death — it's any unwanted change. Kessler lectured at Coca-Cola and General Mills not because they had lots of funerals, but because change management is grief management. People who grieve well live well.
Witnessing someone's grief isn't just emotional support — it's an essential act of healing. Kessler argues grief is a severance and connection heals it. But real witnessing has two steps: seeing the pain AND affirming the person's capacity to recover.
Avoiding grief isn't free — it's exhausting. Kessler's beach ball metaphor nails it: pushing a small balloon down is easy, but holding a massive beach ball underwater takes constant, draining energy. Unattended feelings don't disappear; they just consume you.
Most people try to control their environment to avoid triggers. Kessler flips this entirely: triggers aren't problems to manage around — they're a detailed map to your pain and your healing. Every trigger points directly to what needs attention.
Running from pain doesn't leave it behind — it accelerates the chase. Whatever we run from pursues us, and whatever we face transforms us. Both Kessler and Lewis Howes testify to knowing both roads firsthand.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.